Inventor · disambiguated record
Lixin Shao
Also filed as: SHAO LIXIN
32 granted patents·14 pending applications·512 citations·filing 2010–2025
97Inventor score
Top patents by PatentIndex Score
46 records- 0198US8933085B2Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitorsRODGERS JAMES D·Filed 2011·Granted Jan 13, 2015·96 cites·39 claims
- 0298US8716303B2N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsRODGERS JAMES D·Filed 2010·Granted May 6, 2014·109 cites·74 claims
- 0397US10138248B2Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitorsINCYTE CORP·Filed 2017·Granted Nov 27, 2018·36 cites·24 claims
- 0497US10065963B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2016·Granted Sep 4, 2018·16 cites·14 claims
- 0597US9334274B2N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2014·Granted May 10, 2016·57 cites·34 claims
- 0696US10472368B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2018·Granted Nov 12, 2019·12 cites·28 claims
- 0796US9777003B2Tricyclic heterocycles as bet protein inhibitorsINCYTE CORP·Filed 2016·Granted Oct 3, 2017·25 cites·24 claims
- 0896US9309246B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2014·Granted Apr 12, 2016·33 cites·32 claims
- 0995US11926616B2Aminopyrazine diol compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Mar 12, 2024·2 cites·30 claims
- 1095US11225486B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2020·Granted Jan 18, 2022·4 cites·51 claims
- 1195US11091484B2Tricyclic heterocycles as BET protein inhibitorsINCYTE CORP·Filed 2019·Granted Aug 17, 2021·8 cites·21 claims
- 1295US10640506B2Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitorsINCYTE CORP·Filed 2018·Granted May 5, 2020·19 cites·20 claims
- 1395US10442803B2Tricyclic heterocycles as bet protein inhibitorsINCYTE CORP·Filed 2017·Granted Oct 15, 2019·17 cites·29 claims
- 1494US9193733B2Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitorsINCYTE CORP·Filed 2013·Granted Nov 24, 2015·33 cites·48 claims
- 1593US11926630B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Mar 12, 2024·2 cites·2 claims
- 1693US10975088B2Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitorsINCYTE CORP·Filed 2019·Granted Apr 13, 2021·6 cites·13 claims
- 1793US10479795B2Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitorsINCYTE CORP·Filed 2018·Granted Nov 19, 2019·13 cites·45 claims
- 1890US11046658B2Aminopyrazine derivatives as PI3K-γ inhibitorsINCYTE CORP·Filed 2019·Granted Jun 29, 2021·4 cites·23 claims
- 1988US10738057B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2018·Granted Aug 11, 2020·5 cites·38 claims
- 2087US12365668B2Aminopyrazine diol compounds as PI3K-y inhibitorsINCYTE CORP·Filed 2024·Granted Jul 22, 2025·0 cites·17 claims
- 2187US10669262B2Aminopyrazine diol compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2019·Granted Jun 2, 2020·4 cites·41 claims
- 2286US11691971B2Naphthyridinone compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted Jul 4, 2023·1 cites·46 claims
- 2386US11091491B2Heterocyclic compounds as PI3K-y inhibitorsINCYTE CORP·Filed 2019·Granted Aug 17, 2021·4 cites·37 claims
- 2485US11958861B2Spirocyclic lactams as JAK2 V617F inhibitorsINCYTE CORP·Filed 2022·Granted Apr 16, 2024·1 cites·61 claims
- 2585US2025313550A1AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORSINCYTE CORP·Filed 2025·Application pending·0 cites
- 2684US11352340B2Pyridine and pyridimine compounds as PI3K-gamma inhibitorsINCYTE CORP·Filed 2019·Granted Jun 7, 2022·3 cites·22 claims
- 2783US11078204B2Heterocyclic derivatives as PI3K inhibitorsINCYTE CORP·Filed 2019·Granted Aug 3, 2021·2 cites·46 claims
- 2882US2025388553A1AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORSINCYTE CORP·Filed 2025·Application pending·0 cites
- 2977US2023043959A1Piperidin-4-yl azetidine derivatives as jak1 inhibitorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 3075US12030885B2Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitorsINCYTE CORP·Filed 2021·Granted Jul 9, 2024·0 cites·20 claims
- 3175US11773102B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Oct 3, 2023·0 cites·27 claims
- 3274US11952367B2Pyridine and pyridimine compounds as PI3K-gamma inhibitorsINCYTE CORP·Filed 2022·Granted Apr 9, 2024·0 cites·29 claims
- 3370US12421197B2Aminopyrazine derivatives as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Sep 23, 2025·0 cites·28 claims
- 3470US2020339542A1AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORSINCYTE CORP·Filed 2020·Application pending·0 cites
- 3569US2025101020A1Spirocyclic lactam inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3668US2025333420A1Fused bicyclic pyrimidones as wrn inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3766US2025215006A1Tricyclic compounds as inhibitors of wrnINCYTE CORP·Filed 2024·Application pending·0 cites
- 3864US12006320B2Heterocyclic derivatives as PI3K inhibitorsINCYTE CORP·Filed 2021·Granted Jun 11, 2024·0 cites·33 claims
- 3959US2015087632A1Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as jak inhibitorsINCYTE CORP·Filed 2014·Application pending·0 cites
- 4054US2014206017A1Lysyl oxidase-like 2 assay and methods of use thereofSMITH VICTORIA·Filed 2012·Application pending·0 cites
- 4154US2017269085A1Lysyl oxidase-like 2 assay and methods of use thereofGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 4252US2017190689A1Pyridine and pyridimine compounds as pi3k-gamma inhibitorsINCYTE CORP·Filed 2017·Application pending·0 cites
- 4350US2012309020A1Lysyl oxidase-like 2 assay and methods of use thereofSMITH VICTORIA·Filed 2012·Application pending·0 cites
- 4445US2014120102A1Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)GILEAD SCIENCES INC·Filed 2013·Application pending·0 cites
- 4544US11306079B23-(5-amino-pyrazin-2-yl)-benzenesulfonamide derivatives and related compounds as PI3K-gamma kinase inhibitorsINCYTE CORP·Filed 2018·Granted Apr 19, 2022·0 cites·58 claims
- 4640US2017327595A1Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)GILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lixin Shao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →